The phrase "advanced preference" is correct and usable in written English.
It can be used in contexts where you are discussing a more sophisticated or developed choice or option, often in technology or user settings.
Example: "In the software settings, you can adjust your advanced preference to optimize performance based on your specific needs."
Alternatives: "enhanced choice" or "sophisticated option".
This included knowledge of advanced dementia, preferences for goals of care, health literacy, and, for the video group, comfort with the video decision support tool.
The £29m signing from Hoffenheim made a slow start but Klopp was an admirer from the Bundesliga and clearly regards him as an important player, using him in an advanced role in preference to Christian Benteke in the away games at Chelsea and here, where he showed his class again.
The survey included an innovative stated preference design to collect data that address the potential of advanced transit information systems.
And these new stable releases come with new features such as more advanced syncing (bookmarks, preferences, settings, etc).
Decisions about medical treatment in advanced cancer are preference-sensitive.
While new users appreciate the user-friendly and intuitive interface, more experienced users can also take advantage of the many advanced features and preferences.
But the challenge will be finding common ground between Citicorp's traditional emphasis on advanced technology and Travelers' preference for low-cost, no-frills systems.
The new policy also embraced net conservation gain for biodiversity and states a preference for advanced mitigation mechanisms such as conservation banking or habitat exchanges.
One individual with decision-making capacity and Motor Neurone Disease, had made an advanced expression of treatment preference regarding Percutaneous Endoscopic Gastrostomy.
We have shown here using two different normal/tumour isogenic cell type models that the Apoptin tNTS was able to increase the nuclear accumulation of histones H3 and H2B specifically in cancer cells but not in normal isogenic counterparts, with a preference for advanced tumour phenotypes similar to the Apoptin tNTS alone.
